Biktarvy, formally known as bictegravir, is a effective single-tablet therapy for controlling HIV infection. This drug integrates three essential antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the the viral ability to copy within the body, significantly reducing the viral quantity. For many